The observed severe clinical outcome of COVID-19 in patients with cardiovascular disease and diabetes could be linked with the decreased expression of ACE2, that make them vulnerable to angiotensin 2 proinflammatory pathway [32]. The gene discussed is AGT; the disease is COVID-19.